These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25982183)

  • 1. Differentiating primary central nervous system (CNS) lymphoma from "butterfly glioma": A case report.
    Bragin A; Safouris A; Bourgonjon B; Michotte A; Triantafyllou N; Tsivgoulis G
    J Neurol Sci; 2015 Jul; 354(1-2):114-5. PubMed ID: 25982183
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
    Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
    JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracerebral tumours].
    Chatel M; Bourg V
    Rev Prat; 2004 Apr; 54(8):889-96; quiz 896. PubMed ID: 15274465
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?
    Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Maeshima A; Kayama T; Shibui S
    Clin Neurol Neurosurg; 2012 Nov; 114(9):1217-21. PubMed ID: 22445618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and diagnosis of primary central nervous system lymphoma.
    Fitzsimmons A; Upchurch K; Batchelor T
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):689-703, vii. PubMed ID: 16083830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnosis and treatment of primary central nervous system lymphoma].
    Li Y; Liu F; Liu Y; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):771-3. PubMed ID: 25152136
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis and management of primary CNS lymphoma.
    Roth P; Korfel A; Martus P; Weller M
    Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities.
    Wong ET
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7151s-7157s. PubMed ID: 16203815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.
    Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
    Clin Radiol; 2015 Dec; 70(12):1393-9. PubMed ID: 26382744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system lymphoma.
    Aziz HA; Peereboom DM; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):111-21. PubMed ID: 25436497
    [No Abstract]   [Full Text] [Related]  

  • 11. III. Current concepts in primary central nervous lymphoma.
    Illerhaus G
    Hematol Oncol; 2015 Jun; 33 Suppl 1():25-8. PubMed ID: 26062049
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Reasoning: Vanishing tumor: A 7-year puzzle solved.
    Kelly CM; O'Dowd S; Drake C; McCarthy L; Bermingham N; Fanning N; O'Sullivan SS; O'Reilly S
    Neurology; 2015 Sep; 85(9):e69-73. PubMed ID: 26324866
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary CNS lymphoma: an update on its diagnosis and management].
    Izumoto S
    No Shinkei Geka; 2014 Jun; 42(6):507-21. PubMed ID: 24920738
    [No Abstract]   [Full Text] [Related]  

  • 14. Glioma: a continuing challenge and a mystery?
    Muzumdar D
    Indian J Cancer; 2009; 46(2):79-81. PubMed ID: 19346640
    [No Abstract]   [Full Text] [Related]  

  • 15. Multimodal magnetic resonance imaging in the diagnosis and therapeutical follow-up of brain tumors.
    Housni A; Boujraf S
    Neurosciences (Riyadh); 2013 Jan; 18(1):3-10. PubMed ID: 23291791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary CNS lymphoma and neurologic complications of hematologic malignancies.
    Nayak L; Pentsova E; Batchelor TT
    Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):355-72. PubMed ID: 25837901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy.
    Harting I; Hartmann M; Jost G; Sommer C; Ahmadi R; Heiland S; Sartor K
    Neurosci Lett; 2003 May; 342(3):163-6. PubMed ID: 12757890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary lymphoma of the central nervous system--a diagnostic challenge.
    Deckert M; Brunn A; Montesinos-Rongen M; Terreni MR; Ponzoni M
    Hematol Oncol; 2014 Jun; 32(2):57-67. PubMed ID: 23949943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of primary central nervous system lymphoma presenting diffuse infiltrative leukoencephalopathy.
    Yamamoto T; Kojima K; Koibuchi K; Ito S; Higuchi Y; Iwadate Y; Oide T; Kuwabara S
    Intern Med; 2012; 51(9):1103-6. PubMed ID: 22576396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.